1. Adusumalli, V.E., Gilchrist, J.R., Kucharczyk, N. and Sofia, R.D., Pharmacokinetics of the new antiepileptic drug felbamate in pediatric and adult beagle dogs, Epilepsia, 33 (1992) 955–960.
2. Bebin, E.M., Sofia, R.D. and Dreifuss, F.E., Felbamate toxicity. In: R.H. Levy, R.H. Mattson and B.S. Meldrum (Eds.), Antiepileptic Drugs, 4th Edn, Raven Press, New York, 1995, pp. 823–827.
3. Berger, F.M., The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (Miltown), a new interneuronal blocking agent, J. Pharmacol. Exp. Ther., 112 (1954) 413–423.
4. Berger, F.M., Handley, C.D., Ludwig, B.J. and Lynes, T.E., Central depressant and anticonvulsant activity of compounds isomeric with 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (Miltown), J. Pharmacol. Exp. Ther., 116 (1956) 337–342.
5. Boissier, J.-R., Tardy, J. and Diverres, J.-C., Une nouvelle méthode simple pour explorer l'action `tranquillisante': le test de la cheminée, Med. Exp. (Basel) 3 (1960) 81–83.